EOS IMAGING overview

Regulatory News: EOS imaging (Euronext, FR0011191766-EOSI - PEA PME eligible) (the " Company "), a leading provider of 2D/3D orthopedic imaging and software solutions for 3D anatomical modeling and surgical planning, informs the holders of the bonds convertible into new shares and/or exchangeable for existing shares of the Company (the " Bonds ") that, following the public tender offer on EOS imaging's securities initiated by Alphatec Holdings Inc. (Nasdaq: ATEC) (the " Offer "), the Company has...

Regulatory News: Alphatec Holdings, Inc. (Nasdaq: ATEC), is a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery. Centered on a singular vision to better inform surgery, ATEC today welcomes the EOS imaging (Paris:EOSI) team in a combination forged to improve the predictability of the patient experience in spine from diagnosis through follow up. “ I am thrilled to officially welcome EOS’ teams to the ATEC family,” stated Pat Miles, Chairman and Chief...

Regulatory News: EOS imaging (Euronext, FR0011191766 - EOSI - Eligible PEA - PME) (the "Company"), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, announced that its Board of Directors met today to acknowledge the change of control of the Company following the completion of the first tender offer initiated by Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC”), as a result of which, ATEC holds 89.1% of the common shares and...

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210511006268/en/ Alphatec Holdings, Inc. (Nasdaq: ATEC) and EOS IMAGING, S.A. (Paris:EOSI) are pleased to report strong progress in the tender offer filed by ATEC for the common shares and outstanding convertible bonds (OCEANEs) of EOS imaging, the results of which were published on May 10, 2021, by the Autorité des Marchés Financiers (AMF), with settlement expected to...

Regulatory News: EOS imaging (Euronext, FR0011191766 - EOSI - Eligible PEA - PME) (Paris:EOSI), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, today announces its consolidated annual results for the year to December 31, 2020 as approved by the Board of Directors on April 20, 2021. Unaudited revenues for the first quarter of 2021 also released. A year marked by the successful commercialization of EOSedge and the 400 th global...

Regulatory News: EOS imaging (Euronext, FR0011191766 - EOSI - PEA-PME eligible) (Paris:EOSI), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, today announces its unaudited full-year sales for the financial year ending December 31, 2020. €23.8 million total revenues (+19%) generated over the year 2020 €10.9m in equipment revenues from the billing of 34 imaging systems of which 15 in Q4 2020, to be compared to. €8.5m in...

Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, announces its financial calendar for the year 2021. Event Date * 2020 Full-Year Sales January, 11 2021 (before opening) 2020 Full-Year Results and 2021 First-Quarter Sales April, 20 2021 Ordinary General Meeting June, 17 2021 2021 First-Half Sales July, 21 2021 2021 Half-Year Results...

Regulatory News: EOS imaging (Euronext, FR0011191766 - EOSI - PEA-PME eligible) (Paris:EOSI), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, today announces unaudited third quarter revenues ending September 30, 2020. THIRD QUARTER AND NINE-MONTHS 2020 HIGHLIGHTS €16.2 million total revenues (+32%) generated over the first 9-months of 2020 €6.5m in equipment revenues vs. €4.3m in the first nine-months of 2019 1 19...